Faculty of Social Welfare and Health Sciences, School of Public Health, University of Haifa, Haifa, Israel.
Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Hepatol Commun. 2024 Nov 4;8(11). doi: 10.1097/HC9.0000000000000583. eCollection 2024 Nov 1.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an unhealthy lifestyle. However, there is limited prospective evidence regarding the association between combined lifestyle factors and MASLD. This study aims to test the association of a combination of lifestyle components, expressed as a healthy lifestyle index (HLI), and unhealthful eating behavior habits with MASLD, insulin resistance (IR), liver fibrosis, and metabolic dysfunction-associated steatohepatitis.
A prospective cohort study was conducted among participants of metabolic and hepatic screening surveys. MASLD was evaluated by ultrasonography or controlled attenuation parameter at 2 time points to assess new-onset, persistence, or remission, and IR was estimated by homeostasis model assessment. Presumed liver fibrosis and metabolic dysfunction-associated steatohepatitis were evaluated using FibroMax biomarkers. The HLI was calculated as the sum of 4 lifestyle components: nonsmoking, healthy weight, healthy diet, and physical activity.
The final cohort included 315 subjects with 6.7 years of follow-up, 40-70 years old. In multivariable analyses, a favorable lifestyle (≥3 components) was independently associated with lower odds of new-onset MASLD (OR = 0.42; 95% CI: 0.19-0.90). Similarly, a favorable lifestyle was associated with lower odds of new-onset/persistent (vs. never/remission) MASLD and IR, respectively (OR = 0.49; 95% CI: 0.30-0.80; OR = 0.40; 95% CI: 0.24-0.66). There was a dose-response association between HLI and new-onset/persistent MASLD and IR. A favorable lifestyle was associated with lower odds of new-onset metabolic dysfunction-associated steatohepatitis (OR = 0.50; 95% CI: 0.27-0.95). Adjusting for HLI, unhealthful eating behavior habits were associated with higher odds of MASLD prevalence (OR = 1.81; 95% CI: 1.07-3.06).
Adherence to a healthy lifestyle is prospectively associated with lower odds of MASLD, markers of liver damage, and IR. A holistic approach that considers overall lifestyle and eating behavior may be useful for preventing MASLD.
代谢功能障碍相关脂肪性肝病(MASLD)与不健康的生活方式有关。然而,关于生活方式因素综合与 MASLD 之间的关联,目前还缺乏前瞻性证据。本研究旨在检验健康生活方式指数(HLI)所代表的生活方式综合因素与 MASLD、胰岛素抵抗(IR)、肝纤维化和代谢功能障碍相关脂肪性肝炎之间的关联。
对代谢和肝脏筛查调查的参与者进行前瞻性队列研究。通过超声或控制衰减参数在 2 个时间点评估 MASLD,以评估新发、持续或缓解,并使用稳态模型评估法估计 IR。使用 FibroMax 生物标志物评估假定的肝纤维化和代谢功能障碍相关脂肪性肝炎。HLI 计算为 4 个生活方式成分的总和:不吸烟、健康体重、健康饮食和身体活动。
最终的队列纳入了 315 名年龄在 40-70 岁之间、随访时间为 6.7 年的参与者。多变量分析显示,良好的生活方式(≥3 个因素)与新发 MASLD 的可能性降低独立相关(OR=0.42;95%CI:0.19-0.90)。同样,良好的生活方式与新发/持续(而非从不/缓解)MASLD 和 IR 的可能性降低相关(OR=0.49;95%CI:0.30-0.80;OR=0.40;95%CI:0.24-0.66)。HLI 与新发/持续 MASLD 和 IR 之间存在剂量反应关系。良好的生活方式与新发代谢功能障碍相关脂肪性肝炎的可能性降低相关(OR=0.50;95%CI:0.27-0.95)。调整 HLI 后,不良的饮食行为习惯与 MASLD 患病率升高相关(OR=1.81;95%CI:1.07-3.06)。
坚持健康的生活方式与新发 MASLD、肝损伤标志物和 IR 的可能性降低相关。综合考虑整体生活方式和饮食行为的整体方法可能有助于预防 MASLD。